Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Aug/12/2020
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Bis(5-amidino-2-benzimidazolyl)methane ketone
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Ethyl 2-[(E)-[[1-[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazol-5-yl]cyclopropyl]-pyridin-2-ylmethylidene]amino]oxyacetate
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Metocurine
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
MolPort-000-735-951
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Lifirafenib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Radotinib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Tivantinib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Brincidofovir
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6′-O-acetyl)-β-D-xylopyranosyl-(1 → 2)-β-D-glucopyranoside
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
Torososide B
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
Apilimod
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020
Vacuolin-1
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020
Cyanidin
Potential treatment - theoretical effect Experimental Antiviral Aug/06/2020
RBD mRNA
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/05/2020
S1 mRNA
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/05/2020
Succinylsulfathiazole
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Protirelin
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Sulfaperin
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020